Chapters authored
Orienting Future Trends in Local Ancestry Deconvolution Models to Optimally Decipher Admixed Individual Genome Variations
Rapid advances in sequencing and genotyping technologies have significantly contributed to shaping the area of medical and population genetics. Several thousand genomes are completed with millions of variants identified in the human deoxyribonucleic acid (DNA) sequences. These genomic variations highly influence changes in phenotypic manifestations and physiological functions of different individuals or population groups. Of particular importance are variations introduced by admixture event, contributing significantly to a remarkable phenotypic variability with medical and/or evolutionary implications. In this case, knowledge of local ancestry estimates and date of admixture is of utmost importance for a better understanding of genomic variation patterns throughout modern human evolution and adaptive processes. In this chapter, we survey existing local ancestry deconvolution and dating admixture event models to identify possible gaps that still need to be filled and orient future trends in designing more effective models, which account for current challenges and produce more accurate and biological relevant estimates.
Part of the book: Bioinformatics Tools for Detection and Clinical Interpretation of Genomic Variations
Designing Data-Driven Learning Algorithms: A Necessity to Ensure Effective Post-Genomic Medicine and Biomedical Research
Advances in sequencing technology have significantly contributed to shaping the area of genetics and enabled the identification of genetic variants associated with complex traits through genome-wide association studies. This has provided insights into genetic medicine, in which case, genetic factors influence variability in disease and treatment outcomes. On the other side, the missing or hidden heritability has suggested that the host quality of life and other environmental factors may also influence differences in disease risk and drug/treatment responses in genomic medicine, and orient biomedical research, even though this may be highly constrained by genetic capabilities. It is expected that combining these different factors can yield a paradigm-shift of personalized medicine and lead to a more effective medical treatment. With existing “big data” initiatives and high-performance computing infrastructures, there is a need for data-driven learning algorithms and models that enable the selection and prioritization of relevant genetic variants (post-genomic medicine) and trigger effective translation into clinical practice. In this chapter, we survey and discuss existing machine learning algorithms and post-genomic analysis models supporting the process of identifying valuable markers.
Part of the book: Artificial Intelligence